Home/Filings/4/0001209191-18-020016
4//SEC Filing

Ghiglieri Stephen F 4

Accession 0001209191-18-020016

CIK 0001390478other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 7:59 PM ET

Size

5.8 KB

Accession

0001209191-18-020016

Insider Transaction Report

Form 4
Period: 2018-03-13
Ghiglieri Stephen F
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-03-13+11,00011,000 total
    Exercise: $5.24Exp: 2028-03-12Common Stock (11,000 underlying)
Footnotes (1)
  • [F1]The option shares will vest and became exercisable in equal monthly installments for thirty-six (36) months following the March 13, 2018 grant date, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.

Issuer

SELLAS Life Sciences Group, Inc.

CIK 0001390478

Entity typeother

Related Parties

1
  • filerCIK 0001394548

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:59 PM ET
Size
5.8 KB